Table 3.
Postoperative symptoms of Diosmin and control groups n (%)
| Diosmin group1(n = 43) | Control group2(n = 43) | P value | |
| Minor bleeding | |||
| At 2 wk | 3 (6.97) | 11 (25.58) | 0.0409 |
| At 8 wk | 2 (4.65) | 3 (4.64) | 0.6449 |
| Heaviness | |||
| At 2 wk | 4 (9.30) | 14 (32.56) | 0.0171 |
| At 8 wk | 2 (4.65) | 8 (18.60) | 0.0436 |
| Pruritus | |||
| At 2 wk | 9 (20.93) | 18 (41.86) | 0.0365 |
| At 8 wk | 3 (6.97) | 10 (23.25) | 0.0351 |
| Mucosal discharge | |||
| At 2 wk | 7 (16.28) | 11 (25.58) | 0.2890 |
| At 8 wk | 2 (4.64) | 4 (9.30) | 0.3972 |
1
Patients treated with Diosmin;
2
Patients treated with placebo drug.